Exponent, Inc. (NASDAQ:EXPO) Short Interest Update

Exponent, Inc. (NASDAQ:EXPO) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 1,710,000 shares, a growth of 10.3% from the August 31st total of 1,550,000 shares. Based on an average daily volume of 201,400 shares, the days-to-cover ratio is currently 8.5 days. Currently, 3.4% of the shares of the stock are short sold.

Insider Buying and Selling

In related news, VP John Pye sold 3,956 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total value of $415,380.00. Following the sale, the vice president now directly owns 28,422 shares in the company, valued at approximately $2,984,310. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.10% of the company’s stock.

Institutional Trading of Exponent

Several large investors have recently modified their holdings of EXPO. UBS Group AG boosted its holdings in shares of Exponent by 41.4% during the 4th quarter. UBS Group AG now owns 76,565 shares of the business services provider’s stock worth $6,741,000 after buying an additional 22,410 shares during the period. US Bancorp DE raised its stake in Exponent by 3.2% during the 4th quarter. US Bancorp DE now owns 17,561 shares of the business services provider’s stock valued at $1,547,000 after purchasing an additional 549 shares during the last quarter. Parallel Advisors LLC raised its stake in Exponent by 12.4% during the 4th quarter. Parallel Advisors LLC now owns 1,941 shares of the business services provider’s stock valued at $171,000 after purchasing an additional 214 shares during the last quarter. Focus Financial Network Inc. ADV acquired a new position in Exponent during the 4th quarter valued at $219,000. Finally, TFO Wealth Partners LLC raised its stake in Exponent by 14,975.0% during the 4th quarter. TFO Wealth Partners LLC now owns 1,809 shares of the business services provider’s stock valued at $159,000 after purchasing an additional 1,797 shares during the last quarter. 92.37% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Truist Financial reaffirmed a “buy” rating and set a $120.00 price objective (up from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Exponent Stock Down 1.8 %

EXPO stock traded down $2.11 during trading hours on Tuesday, hitting $113.17. The company’s stock had a trading volume of 169,798 shares, compared to its average volume of 253,868. The company has a market capitalization of $5.74 billion, a PE ratio of 57.23 and a beta of 0.66. Exponent has a 12 month low of $64.61 and a 12 month high of $115.61. The stock has a 50 day moving average price of $106.40 and a two-hundred day moving average price of $96.18.

Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, topping the consensus estimate of $0.50 by $0.07. The company had revenue of $132.43 million during the quarter, compared to the consensus estimate of $130.83 million. Exponent had a net margin of 19.35% and a return on equity of 28.39%. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.50 earnings per share. Sell-side analysts expect that Exponent will post 2.04 earnings per share for the current year.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Investors of record on Friday, September 6th were issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 0.99%. The ex-dividend date was Friday, September 6th. Exponent’s dividend payout ratio is currently 56.57%.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.